Immatics - IMTX Competitors

Immatics (NASDAQ:IMTX) and Agenus (NASDAQ:AGEN) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership and profitability.

Which has preferable valuation and earnings, IMTX or AGEN?

Immatics has higher earnings, but lower revenue than Agenus. Agenus is trading at a lower price-to-earnings ratio than Immatics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Immatics	$41.13 million	12.97	-$110.43 million	$0.67	10.45
Agenus	$98.02 million	5.16	-$220.07 million	-$0.79	-1.92

Is IMTX or AGEN more profitable?

Immatics has a net margin of 24.60% compared to Agenus' net margin of -235.30%. Immatics' return on equity of 40.49% beat Agenus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Immatics	24.60%	40.49%	12.91%
Agenus	-235.30%	-1,159.04%	-53.02%

Does the MarketBeat Community favor IMTX or AGEN?

Agenus received 435 more outperform votes than Immatics when rated by MarketBeat users. However, 70.97% of users gave Immatics an outperform vote while only 70.52% of users gave Agenus an outperform vote.

Company	Underperform	Outperform
Immatics	Outperform Votes 22 70.97%	Underperform Votes 9 29.03%
Agenus	Outperform Votes 457 70.52%	Underperform Votes 191 29.48%

Do institutionals & insiders have more ownership in IMTX or AGEN?

29.1% of Immatics shares are owned by institutional investors. Comparatively, 53.8% of Agenus shares are owned by institutional investors. 4.8% of Agenus shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Does the media favor IMTX or AGEN?

In the previous week, Agenus had 18 more articles in the media than Immatics. MarketBeat recorded 25 mentions for Agenus and 7 mentions for Immatics. Immatics' average media sentiment score of 0.30 beat Agenus' score of 0.24 indicating that Immatics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Immatics	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Agenus	1 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts recommend IMTX or AGEN?

Immatics presently has a consensus target price of $27.00, suggesting a potential upside of 285.71%. Agenus has a consensus target price of $7.10, suggesting a potential upside of 367.11%. Given Agenus' higher possible upside, analysts plainly believe Agenus is more favorable than Immatics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Immatics	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Agenus	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more volatility and risk, IMTX or AGEN?

Immatics has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Comparatively, Agenus has a beta of 1.5, meaning that its stock price is 50% more volatile than the S&P 500.

Summary

Immatics beats Agenus on 9 of the 17 factors compared between the two stocks.